Protein kinase C activation and the development of diabetic complications

Diabetes

Volumn 47, Issue 6, 1998, Pages 859-866

  Koya, Daisuke ^a   King, George L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CAPILLARY PERMEABILITY; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENZYME ACTIVATION; HUMANS; HYPERGLYCEMIA; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN KINASE C; REGIONAL BLOOD FLOW;

EID: 0031860340     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.6.859     Document Type: Review

References (110)

1. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1316-1321, 1988
2. Vlassara H: Advanced glycation end-products and atherosclerosis. Ann Med 28:419-426, 1996
3. Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D: RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 (Suppl. 3):S77-S80, 1996
4. Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ, King GL: Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42:80-89, 1993
5. Greene D, Lattimer SA, Sima AAF: Sorbitol, phosphoinositides and sodium- potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606, 1987
6. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
7. King GL, Ishii H, Koya D: Diabetic vascular dysfunctions: A model of excessive activation of protein kinase C. Kidney Int 60:S77-S85, 1997
8. Derubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes: mechanisms and potential link to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
9. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-b as a key modulator. Diabetes 44:1139-1146, 1995
10. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
11. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614, 1992
12. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB 9:484-496, 1995
13. Liscovitch M, Cantley LC: Lipid second messengers. Cell 77:329-334, 1994
14. Nakanishi H, Brewer KA, Exton JH: Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 268:13-16, 1993
15. Chang EY, Szallasi Z, Acs P, Raizada V, Wolfe PC, Fewtrell C, Blumberg PM, Rivera J: Functional effects of over-expression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3. J Immunol 159:2624-2632, 1997
16. Shiba T, Inoguchi T, Sportsman JR, Heath W, Bursell S. King GL: Correlation of diacylglycerol and protein kinase C activity In rat retina to retinal circulation. Am J Physiol 265:E783-E793, 1993
17. Inoguchi T, Battan R, Handler E, Sportsman ,JR, Heath W, King GL: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89:11059-11063, 1992
18. Craven PA, Davidson CM, DeRubertis FR: Increase in diacylglycerol mass in isolated glomoruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667-674, 1990
19. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A. Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
20. Considine RV, Nyce MR, Allen LE, Morales LM, Triester S, Serrano J, Colberg J, Lanza-Jacoby S, Caro JF: Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia J Clin Invest 95:2938-2944, 1995
21. Saha AK, Kurowski TG, Colca JR, Ruderman NB: Lipid abnormalities In tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol. Am J Physiol 267:E95-E101, 1994
22. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129, 1994
23. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J Clin Invest 83:1667-1675, 1989
24. Yasanare K, Kahno M, Kano H, Yokokawa K, Horio T, Yoshikawa J: Possible involvement of phospholipase and protein kinase C in vascular growth induced by elevated glucose concentration. Hypertension 28:159-168, 1996
25. Inoguchi T, Pu X, Kunisaki M, Higashi S, Feener EP, King GL: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 267:E369-E379, 1994
26. Berne C: The metabolism of lipids in mouse pancreatic islets: the biosynthesis of triacylglycerol and phospholipids. Biochem J 152:667-673, 1975
27. Dunlop ME, Larkins RG: Pancreatic islets synthesize phospholipids de novo from glucose via acyl-dihydroxyacetone phosphate. Biochem Biophys Res Commun 132:467-473, 1985
28. Brindley DN, Sturton RG: Phosphatidate metabolism and its relation to triacylglycerol biosynthesis. In Phospholipids. Hawthorne JN, Ansel GB, Eds. New York, Elsevier, 1982, p. 179-207
29. Holub BJ, Kuksis A: Metabolism of molecular species of diacylglycerol phospholipids. Adv Lipid Res 16:1-125, 1986
30. Ido Y, McHowat J, Chang KC, Arrogori-martelli E, Orfaliam Z, Kilo C, Corr PB, Williamson JR: Neural dysfunction and metabolic imbalances in diabetic rats: prevention by acetyl-L carritine. Diabetes 43:1469-1477, 1994
31. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
32. Kunisaki M, Bursell S-E, Umeda F, Nawata H, King GL: Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377, 1994
33. Koya D, Jirousek MR, Lin Y-W, Ishii H, Kuboki K, King GL: Characteristics of protein kinase C β isoform activation on the gene expression of transforming growth factor β, extracellular matrix components and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
34. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y: Translocation of protein kinase a and ζ in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37:838-841, 1994
35. Feke GT, Buzney SM, Ogasawara H, Fujio N, Goger DG, Spack NP, Gabbay KH: Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 35:2968-2975, 1994
36. Bursell S-E, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA: Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 37:886-897, 1996
37. Small KW, Stefànsson E, Hatchell D: Retinal blood flow in normal and diabetic dogs. Invest Ophthalmol Vis Sci 28:672-675, 1987
38. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell S-E: Normalization of retinal blood flow in diabetic rats with primary intervention using insuling pumps. Invest Ophthalmol Vis Sci 35:981-900, 1994
39. Miyamoto K, Ogura Y, Nishiwaki H, Matsuda N, Honda Y, Kato S, Ishida H, Seino Y: Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. Invest Ophthalmol Vis Sci 37:898-905, 1996
40. Kohner EM: Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44:603-607, 1995
41. Tesfaye S, Malik R, Ward JD: Vascular factors in diabetic neuropathy. Diabetologia 37:847-851, 1994
42. + ATPase defects in diabetic rats (Abstract). Diabetes 46 (Suppl. 1):31A, 1997
43. Takagi C, Bursell S-E, Lin Y-W, Takagi H, Duh E, Jiang Z, Clermont AC, King GL: Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthahnol Vis Sci 37:2504-2518, 1996
44. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
45. Williams B, Gallachen B, Patel H, Orme C: Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by vascular smooth muscle cells in vitro. Diabetes 46:1497-1503, 1997
46. Ditzel J, Schwartz M: Abnormally increased glomerular filtration rates in short-term insulin treated diabetic subjects. Diabetes 16:264-267, 1967
47. Christiansen JS, Gammelgaard J, Frandsen M, Parving HH: Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetes. Diabetologia 20:451-456, 1981
48. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-115, 1981
49. Viberti GC: Early functional and morphological changes in diabetic nephropathy. Clin Nephrol 12:47-53, 1979
50. O'Donnell MP, Kasiske BL, Keane WF: Glomerular hemodynamic structural alterations in experimental diabetes mellitus. FASEB J 2:2339-2347, 1988
51. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: functional immunohistochemical and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
52. Ruan X, Arendshorst WJ: Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol 270:F945-F952, 1996
53. Craven PA, Caines MA, DeRubertis FR: Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes. Metabolism 36:95-103, 1987
54. Perico N, Benigni A, Gabanelli M, Piccinelli A, Ròg M, Riva CD, Remuzzi G: Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats. Diabetes 41:533-538, 1992
55. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92:2889-2896, 1993
56. 2. J Clin Invest 96:733-740, 1995
57. Haneda M, Arakis I, Togaro M, Sugimoto T, Isono M, Kikkawa R: Mitogen activated protein kinase C is activated in glomeruli of diabetic rats and glomorular mesangial cells cultured under high glucose conditions. Diabetes 46:847-853, 1997
58. 2 is phosphorylated and activated by MAP kinase. Cell 72:269-278, 1993
59. Bank N, Aynedjian HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1300-1312, 1993
60. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM: Abnormal renal nemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 265:F886-F895, 1993
61. Komers R, Allen TJ, Cooper ME: Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimentol diabetes. Diabetes 43:1190-1197, 1994
62. Sharma K, Danoff TM, DePiero A, Ziyadeh FN: Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem Biophys Res Commun 207:80-88, 1995
63. 2+/EDRF signaling are due to generation of superoxide anions. Diabetes 45:1386-1395, 1996
64. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J Clin Invest 93:311-320, 1994
65. Muniyappa R, Srinivas PR, Ram JL, Walsh MF, Sowers JR: Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 31:289-295, 1998
66. Nishio E, Watanabe Y: Glucose-induced down-regulation of NO production and inducible NOS expression in cultured rat aortic vascular smooth muscle cells: role of protein kinase C. Biochem Biophys Res Commun 229:857-863, 1996
67. Kamata K, Miyata N, Kasuya Y: Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in native and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 249:890-894, 1989
68. Mayhan WG: Impairment of endothelium-dependent dilatation cerebral arterioles during diabetes mellitus. Am J Physiol 256:H621-H625, 1989
69. 2. Am J Physiol 257:H1327-H1333, 1989
70. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771-776, 1992
71. Tesfamariam B, Brown ML, Cohen RA: Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648, 1991
72. Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, Weigel C, Sherman WR, Eades DM, Kilo C: Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Diabetes 36:813-821, 1987
73. Oliver JA: Adenylate cyclase and protein kinase C mediate opposite actions on endothelial junctions. J Cell Physiol 145:536-542, 1990
74. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AM: Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 85:1991-1998, 1990
75. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J: Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87:31-38, 1991
76. Werth DK, Niedel JE, Pastan I: Vinculin, a cytoskeletal substrate of protein kinase C. J Biol Chem 258:11423-11426, 1983
77. 77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J Cell Physiol 153:62-75, 1992
78. 1 overexpression augments phorbol ester-induced increase in endothelial permeability. J Cell Physiol 166:249-255, 1996
79. Xia P, Aiello LP, Ishii H, Jiang Z, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026, 1996
80. King GL, Shiba T, Oliver J, Inoguchi T, Bursell S-E: Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med 45:179-188, 1994
81. Winegrad AI: Does a common mechanism induce the diverse complications of diabetes? Diabetes 36:396-406, 1987
82. MacGregor LC, Matschinsky FM: Altered retinal metabolism in diabetes. II. Measurement of sodium-potassium ATPase and total sodium and potassium in individual retinal layers. J Biol Chem 261:4052-4058, 1986
83. Williamson JR, Kilo C: Extracellular matrix changes in diabetes mellitus. In Comparative Pathobiology of Major Age-Related Diseases. Scarpelli DG, Migahi G, Eds. New York, Liss, 1984, p. 269-288
84. Lu TT, Van LG, Madri JA: Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. Proc Natl Acad Sci USA 93:11808-11813, 1996
85. Scheinman JL, Fish AJ, Matas AJ, Michael AF: The immunohistopathology of glomerular antigens. II. The glomorular basement membrane, aotomyosin, and fibroblast surface antigens in normal, diseased and transplanted human kidneys. Am J Pathol 90:71-88, 1978
86. Bruneval P, Foidart JM, Nochy D, Camilleri JP, Boriety J: Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus. Hum Pathol 16:477-484, 1985
87. Studer RK, Craven PA, DeRubertis FR: Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high- glucose medium. Diabetes 42:118-126, 1993
88. Ayo SH, Radnik RA, Garoni J, Glass II WK. Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136:1339-1348, 1990
89. Ayo SH, Radnik RA, Glass II WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991
90. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y: Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34:198-200, 1991
91. Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andreani D, Galli G, Casini A, Bianchi S, Rotella CM, Mario UD: Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490, 1994
92. 1 (IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 267:F632-F638, 1994
93. MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE: Transforming growth factor β, Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
94. Suzuki S, Ebihara I, Tomino Y, Koide H: Transcriptional activation of matrix genes by transforming growth factor beta 1 in mesangial cells. Exp Nephrol 1:229-237, 1993
95. Nakamura T, Miller D, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells in regulated by transforming growth factor-β1. Kidney Int 41:1213-1221, 1992
96. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
97. Sharma K, Ziyadeh FN: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267:F1094-F1101, 1904
98. Pankewycz OG, Guan J-X, Bolton WK, Gomez A, Benedict JF: Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int 46:748-758, 1994
99. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
100. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGK-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 40:522-530, 1996
101. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin converting enzyme inhibitor on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
102. Chappey O, Dosquet C, Wautier MP, Wautier JL: Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 27:97-108, 1997
103. Kunisaki M, Bursell S-E, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL: Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269:E239-E246, 1995
104. Tasinato A, Boscoboinik D, Bartoli GM, Maroni P, Azzi A: d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition and is independent of its antioxidant properties. Proc Natl Acad Sci USA 92:12190-12194, 1995
105. Koya D, Lee I-K, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunctions in diabetic rats by treatment of d-α-tocopherol. J Am Soc Nephrol 803:426-435, 1997
106. Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, Nishizuka Y: Activation of protein kinase C by tyrosine phosphorylation in response to H202. Proc Natl Acad Sci USA 94:11233-11237, 1997
107. Raman M, Nesto RW: Heart disease in diabetes mellitus. Endocrinol Metab Clin North Am 25:425-438, 1990
108. Wakasaki H, Koya D, Schuen FJ, Jirousek MR, Ways DK, Holt BD, Walsh RA, King GL: Targeted overexpression of protein kinase C isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 94:9320-9325, 1997
109. Porte D Jr, Schwartz MW: Diabetes complications: why is glucose potentially toxic? Science 272:699-700, 1996
110. Nicolucci A, Carinci F, Cavaliere D, Scorpiglione N, Belfiglio M, Labbrozzi D, Mari E, Benedetti MM, Tognoni G, Liberati A: A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy: the Italian Study Group: the St. Vincent Declaration. Diabet Med 13:1017-1026, 1996